M. Durán-Galván et al. / Tetrahedron 66 (2010) 7707e7719
7715
2953, 1953, 1248 cmꢂ1; HRMS (ESI) calcd for C16H24OSi (MþH)
film) 3408, 2953, 1953, 1247 cmꢂ1; HRMS (ESI) calcd for C15H22OSi
(MþLi) 253.1600, found 253.1596. Enantiomeric excess determined
by HPLC (250 nm) using a ChiralPAK AD-H column (hexanes/iso-
261.1675, found 261.1668.
4.2.2. 1-(Naphthalen-2-yl)-2-((trimethylsilyl)methyl)buta-2,3-dien-
propanol¼98:2, flow rate¼0.6 ml/min) retention time¼17.8 min
18
1-ol (2j). Obtained as a light yellow oil (51 mg, 0.18 mmol, 60%). 1H
(major), 14.0 (minor). [
a
]
e106.7 (c 1.0, CHCl3).
D
NMR (CDCl3, 300 MHz)
d
8.24(d, J¼8.3 Hz, 1H), 7.88 (d, J¼8.3 Hz,
1H), 7.82 (d, J¼8.3 Hz, 1H), 7.64 (d, J¼6.2 Hz, 1H), 7.51 (m, 3H), 5.78
(m, 1H), 5.01 (q, J¼2.8, 2.8 Hz, 2H), 2.31 (d, J¼4.5 Hz 1H), 1.43e1.36
(dt, J¼15.1, 2.9 Hz, 1H), 1.13e1.05 (dt, J¼15.1, 2.9 Hz, 1H), 0.0 (s, 9H).
4.3.3. (R)-1-o-tolyl-2-((trimethylsilyl)methyl)buta-2,3-dien-1-ol
(2cc). Obtained as a clear oil (38 mg, 0.15 mmol, 77%, 59% ee) 1H
NMR (CDCl3, 300 MHz)
d 7.41 (m, 1H), 7.18 (m, 3H), 5.24 (m, 1H),
13C NMR (75 MHz, CDCl3)
d
207.0, 137.1, 134.2, 131.6, 128.9, 128.8,
4.94 (q, J¼3.0 Hz, 2H), 2.37 (s, 3H), 2.07 (d, J¼4.8 Hz 1H), 1.36e1.28
126.3, 125.8, 125.4, 125.1, 124.2, 104.8, 79.6, 73.0, 17.0, ꢂ0.8. IR (thin
film) 3386, 3061, 2953, 1952, 1248, 1056 cmꢂ1; HRMS (ESI) calcd for
C18H22OSi (MþLi) 289.1600, found 289.1594.
(dt, J¼2.9, 15.1 Hz, 1H), 1.06e0.99 (dt, J¼2.9, 15.1 Hz, 1H), 0.02 (s,
9H). 13C NMR (75 MHz, CDCl3)
d 205.4, 139.5, 136.3, 130.5, 127.6,
126.7, 125.9, 104.1, 79.2, 72.1, 19.3, 16.5, ꢂ1.1 IR (thin film) 3358,
2953, 1955, 1247 cmꢂ1; HRMS (ESI) calcd for C15H22OSi (MþLi)
253.1600, found 253.1597. Enantiomeric excess determined by
HPLC (210 nm) using a ChiralPAK AD-H column (hexanes/iso-
4.2.3. 1-(4-Methoxyphenyl)-2-((trimethylsilyl)methyl)buta-2,3-dien-
1-ol (2k). Obtained as yellow oil (30 mg, 0.11 mmol, 56%). 1H NMR
(CDCl3, 300 MHz)
d
7.32e7.28(d, J¼8.8 Hz, 2H), 6.91e6.87 (d,
propanol¼98:2, flow rate¼0.6 ml/min) retention time 12.8 min
19
J¼8.8 Hz, 2H), 5.01 (q, J¼2.8 Hz, 2H), 4.94 (m, 1H), 3.82 (s, 3H), 2.23
(major), 11.3 (minor). [
a]
ꢂ49.3 (c 1.0, CHCl3).
D
(br s, 1H), 1.31e1.23 (dt, J¼15.0, 2.9 Hz, 1H), 1.06e0.98 (dt, J¼15.0,
2.9 Hz, 1H), 0.02 (s, 9H). 13C NMR (75 MHz, CDCl3)
d
204.6, 159.5,
4.3.4. (S)-1-(2-Bromophenyl)-2-((trimethylsilyl)methyl)buta-2,3-
134.3, 128.5, 113.9, 105.6, 80.1, 74.6, 55.5, 17.3, ꢂ0.8; IR (thin film)
3428, 2954, 1953, 1248, 1118 cmꢂ1; HRMS (ESI) calcd for C15H22O2Si
(Mþ Li) 269.1549, found 269.1543.
dien-1-ol (2dd). Obtained as a yellow oil (44 mg, 0.14 mmol, 72%,
68% ee) 1H NMR (CDCl3, 300 MHz)
d 7.52e7.44 (m, 2H), 7.33 (td,
J¼1.57, 7.67 Hz, 1H), 7.33 (td, J¼1.92, 7.67 Hz, 1H), 5.42 (m, 1H), 4.94
(q, J¼3.09 Hz, 2H), 2.29 (d, J¼6.95 Hz 1H), 1.39e1.33 (dt, J¼2.8,
15.0 Hz, 1H), 1.16e1.08 (dt, J¼2.6, 15.0 Hz, 1H), 0.0 (s, 9H). 13C NMR
4.3. General method for the preparation of enantioenriched
allenic alcohols
(75 MHz, CDCl3)
d 205.4, 141.0, 132.8, 129.1, 128.8, 127.6, 123.7,
104.16, 79.7, 73.7, 16.8, ꢂ1.1; IR (thin film) 3384, 2953, 1953 cmꢂ1
;
Inside a nitrogen atmosphere drybox, a mixture of CrCl2
(1.2 mg, 0.01 mmol), Mn powder (325 mesh, 22 mg, 0.4 mmol),
and carbazole ligand 1ab (5.5 mg, 0.01 mmol) were added to
a 2-dram vial. Then, the vial was capped with a Teflon lid and it
was removed from the drybox. Freshly distilled CH3CN (2 mL) was
added via syringe and a yellow suspension resulted. This was
HRMS (ESI) calcd for C14H19BrOSi (MꢂOH) 293.0356, found
293.0348; Enantiomeric excess determined by HPLC (250 nm) us-
ing a ChiralPAK AD-H column (hexanes/isopropanol¼98:2, flow
rate¼0.6 ml/min) retention time¼15.5 min (major), 13.9 (minor).
[a
]
23 ꢂ74.5 (c 1.0, CHCl3).
D
followed by addition of i-Pr2NEt (10
m
L, 0.06 mmol) and the mix-
4.3.5. (R)-1-(4-(Trifluoromethyl)phenyl)-2-((trimethylsilyl)methyl)-
buta-2,3-dien-1-ol (2ee). Obtainedasayellowoil (53 mg, 0.17 mmol,
ture was stirred for 5 min. After this time, (4-bromo-2-butyn-1-yl)
trimethylsilane (61 mg, 0.3 mmol) was added and the solution was
allowed to stir for 30 min. Next, the aldehyde (0.2 mmol) and
88%, 72% ee) 1H NMR (CDCl3, 300 MHz)
d
7.64e7.58 (d, J¼8.4 Hz, 2H),
7.52e7.46 (d, J¼8.4 Hz, 2H), 5.06 (m, 1H), 5.00 (q, J¼2.8, 2.9 Hz, 2H),
TMSCl (28 m
L, 0.22 mmol) were successively added at 0 ꢀC. The
2.31 (d, J¼4.75 Hz, 1H), 1.29e1.21 (dt, J¼2.9, 15.1 Hz, 1H), 1.06e0.98
mixture was stirred at rt for 48 h or until the reaction was com-
pleted as judged by TLC. HCl (1 M) was added and the obtained
green solution was stirred until the alcohol is completely depro-
tected as judged by TLC. The mixture was then extracted with
EtOAc. The mixed organic phases were washed with brine, dried
over MgSO4, and concentrated under reduced pressure to give
a dark orange oil. The residue was purified by flash chromato-
graphy using EtOAc/hexanes (1:50 to 1:9) as eluent.
(dt, J¼2.9,15.1 Hz,1H), 0.02 (s, 9H).13C NMR (75 MHz, CDCl3)
d 204.9,
146.06,127.28,125.22 (q, J¼3.72, 3.76 Hz),104.69, 79.94, 74.63,16.46,
ꢂ1.15; IR (thin film) 3307, 2956, 2895, 1951, 1326, 1249 cmꢂ1; HRMS
(ESI) calcd for C15H19F3OSi (MþLi) 307.1317, found 307.1320; Enan-
tiomeric excess determined by HPLC (250 nm) using a ChiralPAK AD-
H column (hexanes/isopropanol¼98:2, flow rate¼0.6 ml/min) re-
23
tention time¼13.55 min (major), 10.17 (minor). [
a
]
ꢂ101.9 (c 1.0,
D
CHCl3).
4.3.1. (R)-1-Phenyl-2-((trimethylsilyl)methyl)buta-2,3-dien-1-ol
4.3.6. (R)-1-(4-Bromophenyl)-2-((trimethylsilyl)methyl)buta-2,3-
dien-1-ol (2ff). Obtained as a clear oil (37 mg, 0.12 mmol, 60%, 74%
(2aa)10. Obtained as a clear oil (40 mg, 0.17 mmol, 88%, 78% ee) 1H
NMR (CDCl3, 300 MHz)
d
7.36e7.27(m, 5H), 4.98 (m, 3H), 2.23 (d,
ee) 1H NMR (CDCl3, 300 MHz)
d
7.48e7.44 (d, J¼8.559 Hz, 2H),
J¼4.5 Hz 1H), 1.30e1.23 (dt, J¼15.3, 2.4 Hz, 1H), 1.07e0.94 (dt,
7.25e7.21 (d, J¼8.37 Hz, 2H), 4.98 (q, J¼3.2 Hz, 2H), 4.94 (m,1H), 2.21
(d, J¼4.4 Hz 1H), 1.28e1.20 (dt, J¼2.7, 15.1 Hz, 1H), 1.04e0.96 (dt,
J¼2.8, 15.0 Hz, 1H), ꢂ0.03 (s, 9H). 13C NMR (75 MHz, CDCl3) 204.6,
J¼14.2, 2.6 Hz, 1H), 0.0 (s, 9H). 13C NMR (75 MHz, CDCl3)
d 204.7,
141.9, 128.3, 127.8, 127.0, 105.1, 79.7, 74.9, 16.8, ꢂ1.1; IR (thin film)
3387, 3029, 2954, 1952, 1247 cmꢂ1; HRMS (ESI) calcd for C14H20OSi
(MꢂOH) 215.1251, found 215.1252. Enantiomeric excess determined
by HPLC (250 nm) using a ChiralPAK AD-H column (hexanes/iso-
propanol¼98:2, flow rate¼0.6 ml/min) retention time¼14.3 min
141.0, 131.3, 128.8, 121.6, 104.9, 80.1, 74.4, 16.6, ꢂ0.9
d; IR (thin film)
3422, 2953, 1952, 1247 cmꢂ1; HRMS (ESI) calcd for C14H19BrOSi
(MꢂH) 309.0310, found 309.0314. Enantiomeric excess determined
by HPLC (250 nm) using a ChiralPAK AD-H column (hexanes/iso-
propanol¼98:2, flow rate¼0.6 ml/min) retention time¼18.4 min
(major), 13.0 (minor). [
a
]
D
23 ꢂ107.2 (c 1.0, CHCl3).
(major), 14.6 (minor). [
a
]
20 ꢂ69.8 (c 1.0, CHCl3).
D
4.3.2. (R)-1-p-Tolyl-2-((trimethylsilyl)methyl)buta-2,3-dien-1-ol
(2bb). Obtained as a clear oil (27 mg, 0.17 mmol, 75%, 70% ee) 1H
4.3.7. (R)-1-Cyclohexyl-2-((trimethylsilyl)methyl)buta-2,3-dien-1-ol
NMR (CDCl3, 300 MHz)
d
7.29e7.24 (d, J¼8.0 Hz, 2H), 7.19e7.14 (d,
(2gg). Obtained as a light yellow oil (32 mg, 0.14 mmol, 67%, 68%
J¼8.0 Hz, 2H), 5.01 (q, J¼2.8 Hz, 2H), 4.94 (m, 1H), 2.36 (s, 3H), 2.23
(d, J¼4.5 Hz 1H), 1.30e1.23 (dt, J¼2.7, 15.0 Hz, 1H), 1.05e0.97 (dt,
ee) 1H NMR (CDCl3, 300 MHz)
d
4.80 (q, J¼2.8 Hz, 2H), 3.67 (m, 1H),
1.79e0.81 (m, 13H). 13C NMR (75 MHz, CDCl3)
d
206.4, 104.5, 79.4,
J¼2.8, 15.0 Hz, 1H), 0.0 (s, 9H). 13C NMR (75 MHz, CDCl3)
d
204.6,
77.6, 42.3, 31.1, 28.1, 27.5, 27.4, 27.1, 17.7, 0.05; IR (thin film) 3415,
139.0, 137.5, 129.0, 126.9, 105.2, 79.7, 74.7, 21.2, 17.0, ꢂ1.0; IR (thin
2925, 2852, 1952, 1247 cmꢂ1; HRMS (ESI) calcd for C14H26OSi